Hyperion Therapeutics IPO Info

Hyperion Therapeutics

Company Name: Hyperion Therapeutics
Stock Symbol: HPTX
Exchange: NASDAQ
Status: Priced
IPO Date: 7/26/2012
IPO Price: 10.00 (12.80%)
Underwriters
Leerink Swann, Cowen and Company, Needham & Company

Amount of Offering: N/A
Number of Shares Offered: 5 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Hyperion is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.

SEC Filings

News Headlines